Element Biosciences: Shawn Levy

Feb 15, 2022

Shawn Levy has joined sequencing technology company Element Biosciences as senior VP of applications and scientific affairs. He comes to Element from Discovery Life Sciences, where he was CSO. Before that, he headed the genomics services laboratory at the HudsonAlpha Institute for Biotechnology, where he remains a faculty investigator. Levy holds a PhD in biochemistry from Emory University School of Medicine.

Breaking News

WHO Approves Abbott Molecular Mpox Assay
Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith
Participant Health Privacy at Risk From Single-Cell RNA Sequencing Data, Study Suggests
With $40M in Funding, Cancer AI Alliance Aims to Pool Data, Computing Resources to Boost Research
Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test

Element Biosciences: Shawn Levy

WHO Approves Abbott Molecular Mpox Assay

Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith

Participant Health Privacy at Risk From Single-Cell RNA Sequencing Data, Study Suggests

With $40M in Funding, Cancer AI Alliance Aims to Pool Data, Computing Resources to Boost Research

Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test